Protagonist Therapeutics, Inc. | ||||
NGM : PTGX || Location: United States | ||||
$26.61+1.0 (+3.9%) |
0.3 M | 25.71 - 26.99 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 3.439 M |
March 15, 2024 | 3.418 M |
Feb. 29, 2024 | 2.936 M |
Feb. 15, 2024 | 2.780 M |
Jan. 31, 2024 | 2.610 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.03 | 0.44 | 1397.94% |
09/30/2023 | -0.71 | -0.58 | 18.04% |
06/30/2023 | -0.66 | -0.68 | -2.98% |
03/31/2023 | -0.74 | -0.67 | 9.61% |
12/31/2022 | -0.65 | -0.69 | -5.97% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 58.275M | Shares Float | 40.661M |
Short Float | 3.439M | Market Cap | 1550.70M |
Institution ownership | 0.00% | Insider ownership | 1.707% |
Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.39 | Forward EPS | -0.81 |